GSK

Vancouver, Canada Founded: 2003 • Age: 23 yrs Listed Acquired By GSK
GSK is engaged in developing biopharmaceutical solutions globally.

About GSK

GSK is a Healthcare company based in Vancouver (Canada) founded in 2003, and was acquired by GSK in April 2022. GSK is engaged in developing biopharmaceutical solutions globally. It operates on a Direct-to-Consumer (D2C) and Professional Services model. GSK has raised $74.98 million across 3 funding rounds from investors including Orbimed, Janus Henderson Investors and RA Capital. GSK offers products and services including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions. Its focus areas include Pharmaceuticals and Biopharmaceuticals. Its legal entity is GSK plc.

Company details

GSK, a leading biopharmaceutical company, is focused on uniting science, technology, and talent to address diseases. Operations are centered in therapeutic areas such as respiratory, immunology, inflammation, oncology, HIV, and infectious diseases. Solutions are developed to improve global health access, particularly in lower-income regions. Commitment is shown towards environmental sustainability and ethical standards. Research and development efforts are prioritized to impact 2.5 billion people by the decades end. Partnerships and strategic programs are utilized to enhance healthcare delivery across diverse markets.

Key Metrics
  • Total Equity Funding
    $74.98M (USD)

    in 3 rounds

  • Latest Funding Round
    $59.5M (USD), Series D

    May 2014

  • Investors
    Orbimed

    & 13 more

  • Acquired by
    GSK

    (Apr 2022)

Products & Services of GSK

GSK offers a comprehensive portfolio of products and services, including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions.

Respiratory Treatments
Pharmaceuticals

Solutions for respiratory conditions are developed and provided.

Oncology Therapies
Pharmaceuticals

Cancer treatments are researched and offered for patients.

HIV Medications
Pharmaceuticals

HIV therapies are created to manage the condition.

Infectious Disease Solutions
Pharmaceuticals

Treatments for infectious diseases are developed and distributed.

Apps and channels of GSK

its YouTube channel ViiV Healthcare has 133 subscribers and 30 videos.

ViiV Healthcare
YouTube 133 subscribers 30 videos Autos & Vehicles
Open channel

Videos from GSK

The most watched videos on GSK's YouTube channel, ViiV Healthcare (133 subscribers). Click a video to play it here.

Bridging the gap between clinical trials and real life in HIV care
532.5K views
The potential of bNAbs
11.4K views
Take My Hand
2.2K views
We can end the HIV epidemic, FULL STOP.
1.9K views

More on ViiV Healthcare.

Funding Insights of GSK

GSK has successfully raised a total of $74.98M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $59.5 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $74.98M
  • Total Rounds 3
  • Last Round Series D β€” $59.5M
  • First Round $4.3M

    (Jun 2013)

  • Investors Count 13

All 3 funding rounds of GSK with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2014$59.5MSeries D–Vivo Capital
Dec 2013$11.18MSeries B––
–
Jun 2013$4.3MSeries A––
–
Valuation history

14 investors in total: 14 institutional.

Investors in GSK

GSK has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed, Janus Henderson Investors and RA Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital and private equity firm
vivocapital.comPalo Alto, United States
Healthcare sector private equity investments are managed by the firm.
1991frazierhealthcare.comSeattle, United States
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
1989orbimed.comNew York, United States
Private markets investment management with strategies in equity, credit, and secondary investments.
adamsstreetpartners.com
hopenls.com
Sectoral Asset Management is focused on global healthcare investment.
2000sectoral.comMontreal, Canada
Multiple sectors are targeted for venture capital investments.
1934janushenderson.comLondon, United Kingdom
capitalmidwest.com
A venture capital firm focused on life sciences investments.
2005apjohnventures.comKalamazoo, United States
Venture capital and private equity investments are managed by Amherst Fund.
2003amherstfund.comAnn Arbor, USA
Premium access

Investor details for GSK

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of GSK

962 people are tracked at GSK (578 in leadership, 9 in board & advisors, 375 in team).

NameRoleGroup
Enoch Acquah
Production Value Stream DirectorLeadership
Rosirene Paczkowski
DirectorLeadership
Avijit Ray
DirectorLeadership
John Hong
Medicine Supply Chain Leader (director)Leadership
Angela Avila
Finance DirectorLeadership
Sarit Cohen-Rabbie
Clinical Development Director, ImmunologyLeadership
Renata Scofield
Global Senior Director, Environmental StewardshipLeadership
David Redfern
President, Corporate DevelopmentLeadership
Jiaying Ji
Head Of China Talent AcquisitionLeadership
Sean Evans
Director, Strategic AlliancesLeadership
Sergio Serrano Caballero
Digital Business PartnerLeadership
Heidi Feldser
Scientific DirectorLeadership
Kyle Robinson
Associate Director External OperationsLeadership
Christophe Lambert
Head Of Viral Computational GenomicsLeadership
Rajesh Gurumurthy
Director Strategic Procurement (senior Principal Product Owner) Global Products & TechnologyLeadership
Victoria Sanchez Zini
Director R&d Strategy - RD Strategy & Portfolio Management / Office Of The CSOLeadership
Cristelle Noirhomme
Head Of Belgium Corporate Government AffairsLeadership
Yogitaa Gahlot Saha
Director - FinanceLeadership
Raye Yohannes Melka
Associate Director Downstream Process DevelopmentLeadership
Andrea Haynes
Senior Scientific Director, Head Of Experimental Quantitative PharmacologyLeadership

942 more people are available in the full profile.

Premium access

Complete people profiles for GSK

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of GSK

5 dated milestones of GSK across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded GSK is founded.
  2. Funding First funding round of $4.3M.
  3. Funding Latest funding round, Series D, of $59.5M.
  4. IPO Lists on the stock exchange (IPO).
  5. Exit Acquired by GSK.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Gsk

Premium access

Complete news archive for GSK

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about GSK

GSK was founded in 2003 and raised its 1st funding round 10 years after it was founded.

GSK is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.

GSK is a funded company, having raised a total of $74.98M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4.3M, raised on Jun 2013.

GSK, a leading biopharmaceutical company, is focused on uniting science, technology, and talent to address diseases. Operations are centered in therapeutic areas such as respiratory, immunology, inflammation, oncology, HIV, and infectious diseases. Solutions are developed to improve global health access, particularly in lower-income regions. Commitment is shown towards environmental sustainability and ethical standards. Research and development efforts are prioritized to impact 2.5 billion people by the decades end. Partnerships and strategic programs are utilized to enhance healthcare delivery across diverse markets.

GSK offers Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions.

GSK has 14 investors. Key investors include Orbimed, Janus Henderson Investors, RA Capital, Frazier Healthcare Partners, and GSK.

GSK operates through Gsk Plc.

Yes. GSK was acquired by GSK in April 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available